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Abstract
Chemerin is an adipokine proposed to link obesity and chronic inflammation of adipose tissue. Genetic factors determining
chemerin release from adipose tissue are yet unknown. We conducted a meta-analysis of genome-wide association studies
(GWAS) for serum chemerin in three independent cohorts from Europe: Sorbs and KORA from Germany and PPP-Botnia
from Finland (total N = 2,791). In addition, we measured mRNA expression of genes within the associated loci in peripheral
mononuclear cells by micro-arrays, and within adipose tissue by quantitative RT-PCR and performed mRNA expression
quantitative trait and expression-chemerin association studies to functionally substantiate our loci. Heritability estimate of
circulating chemerin levels was 16.2% in the Sorbs cohort. Thirty single nucleotide polymorphisms (SNPs) at chromosome 7
within the retinoic acid receptor responder 2 (RARRES2)/Leucine Rich Repeat Containing (LRRC61) locus reached genome-
wide significance (p,5.061028) in the meta-analysis (the strongest evidence for association at rs7806429 with
p = 7.8610214, beta =20.067, explained variance 2.0%). All other SNPs within the cluster were in linkage disequilibrium
with rs7806429 (minimum r2 = 0.43 in the Sorbs cohort). The results of the subgroup analyses of males and females were
consistent with the results found in the total cohort. No significant SNP-sex interaction was observed. rs7806429 was
associated with mRNA expression of RARRES2 in visceral adipose tissue in women (p,0.05 after adjusting for age and body
mass index). In conclusion, the present meta-GWAS combined with mRNA expression studies highlights the role of genetic
variation in the RARRES2 locus in the regulation of circulating chemerin concentrations.
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Introduction
Chemerin has been extensively studied as an adipokine
associated with obesity and related phenotypes [1–4]. It is secreted
from adipose tissue as an 18-kDa precursor protein which is
activated by several extracellular cleavage steps [5–7]. The class of
proteases responsible for the transformation of pro-chemerin to
chemerin also determines pro-inflammatory or anti-inflammatory
function of the protein. Interestingly, proteolytic processing is also
suggested to be involved in the inactivation of the protein. By
binding with the G protein-coupled receptor chemokine-like
receptor 1 (CMKLR1) chemerin activates nuclear factor-kB and
MAPK pathways [1,6,7].
Chemerin is highly expressed in white adipose tissue and its
expression and secretion increases with adipogenesis [1,5]. From a
physiological point of view, chemerin was initially reported as a
chemo-attractant for several types of immune cells [6]. Because of
its role in chemotaxis of dendritic cells and macrophages, this
adipokine is proposed to be a critical link between obesity and
chronic inflammation of adipose tissue. Serum chemerin concen-
trations have been shown to be moderately heritable, with about
25% of variation attributed to genetic factors [8]. A recent
genome-wide association analysis (GWAS) in 523 Mexican-
American individuals revealed 7 loci moderately associated with
chemerin serum concentrations. However, none of the suggested
variants achieved genome-wide significance level and a replication
cohort was not available in that study [8]. The single nucleotide
polymorphism (SNP) showing the strongest evidence of association
(rs347344; p = 1.461026) was located within epithelial growth
factor-like repeats and discoidin I-like domains 3 (EDIL3) playing
an important role in angiogenesis, a key step in adipose tissue
expansion in obesity [8].
Notably, variants in retinoic acid receptor responder 2
(RARRES2), the gene encoding chemerin, have been shown to
be associated with increased visceral fat mass in non-obese subjects
[9] and with increased incidence of the metabolic syndrome [10].
Co-expression network analyses in gluteal and abdominal adipose
tissue showed that rs10282458 in the RARRES2/REPIN1 region
modulated RARRES2 expression and was associated with body
mass index [11].
In summary, none of the previously reported loci has either
reached genome-wide significance levels or has been sufficiently
replicated. Thus, the heritability of serum chemerin concentra-
tion still remains largely unexplained. Therefore, we conducted a
meta-analysis of GWAS for serum chemerin in three independent
cohorts: the Sorbs (N= 824) and KORA (N= 1630) from
Germany and the PPP-Botnia (N= 337) from Finland.
To functionally support our GWAS findings, we performed
more detailed analyses in the Sorbs cohort comprising interac-
tion, gene expression quantitative trait loci, expression–
association and causal analyses of peripheral blood mononuclear
cells (PBMC) mRNA expression profiles of genes mapping
within the associated loci as well as Gene expression analyses in
adipose tissue by quantitative RT-PCR in an independent
sample.
Results
Association of serum chemerin concentrations with
obesity and parameters of glucose metabolism in the
Sorbs cohort
Serum chemerin concentrations were positively correlated with
BMI (p = 2.4610210, beta 0.442) and % body fat (p = 7.961029,
beta = 0.008) but not with fat distribution (Table 1). Furthermore,
chemerin levels correlated with elevated fasting insulin
(p = 3.561024, beta = 0.071), HOMA-IR (p= 0.001, beta = 0.065)
and AUCglucose (p = 0.033, beta = 0.145). Interestingly, serum
chemerin concentrations are also positively associated with
adipocyte fatty acid binding protein (AFABP) and progranulin
levels but not with vaspin and adiponectin concentrations
(Table 1). Additionally, chemerin levels were negatively correlated
with renal function (p = 7.861025, beta =20.255).
Re-estimation of the heritability of chemerin
concentration
The significant degree of relatedness observed in the Sorbs
cohort allowed us to estimate the heritability of chemerin
concentration, which was 16.2%, using a mixed-model approach
proposed by Amin et al. and Aulchenko et al. [12,13].
Genome wide meta-analysis for association with serum
chemerin concentrations
No general inflation of meta-analysis statistics was observed
(l=0.99). Based on the fixed effects model, 30 SNPs on
chromosome 7 reached genome-wide significance (p,5.061028)
in the meta-analysis of Sorbs (n = 824), KORA (n=1630) and PPP
(n= 337, Table 2). All of these SNPs were consistently associated
with p,1023 in both the KORA and the Sorbs cohorts but not in
the PPP cohort. However, effect sizes and directions of effects were
concordant between all three studies. The strongest evidence for
association was observed for rs7806429 at chromosome 7
(p = 7.8610214, beta =20.067, explained variance 2.0%, Table 2
and S1 Figure). All other SNPs with p,5.061028 were in linkage
disequilibrium (LD) with rs7806429 (minimal r2 = 0.43 in the
Sorbs cohort). When adjusting chemerin levels for rs7806429,
these SNPs are no longer significant in the Sorbs cohort (minimal
p-value 0.19), i.e. no independent effects of other SNPs at this
locus were detected. A regional association plot is provided in
Fig. 1. The obvious gap detectable between positions 149.58 Mbp
and 149.64 Mbp is caused by low imputation efficacy of
Affymetrix 500 K SNP panels resulting in post-imputation quality
drop-outs in the Sorbs cohort and in the Botnia study.
The results of the subgroup analyses in males and females were
consistent with data in the total cohort (S2 Table). No significant
interaction of rs7806429 and sex was observed (p= 0.83 in the
Sorbs cohort).
Of note, 4 SNPs not in LD with rs7806429 have been identified
with p-values,1026 using the fixed effect model in at least one of
the groups ‘‘all’’, ‘‘male’’ or ‘‘female’’ (S2 Table). We consider
these results as being suggestive but requiring further investiga-
tions. Thus, two other loci on chromosomes 3 (lead SNP:
Genome Wide Meta-analysis for Chemerin Serum Levels
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rs2594989 in ATG7 - Autophagy Related 7) and 15 (lead SNP:
rs8027521) should be considered. The first locus showed consistent
effects across all studies and subgroups but failed to reach genome-
wide significance. The significant effect of the locus on chromo-
some 15 was primarily due to the strong effect size observed in the
Sorbs cohort (S2 Table).
We analysed the correlation of our top-hits with published
GWAS-hits of the GWAS catalogue (downloaded on 12th Sept.,
2013). The maximum r2 was 0.2 for the hit on chromosome 15,
suggesting there are no pleiotropic effects regarding published
GWAS traits [14].
Finally, we performed a Mendelian randomization analysis
using our top-SNP as an instrumental variable. We considered
different parameters of obesity or the metabolic syndrome as
possible causal endpoints of chemerin (Table 1). Results are
presented in S6 Table. Analysis suggests a causal relationship of
chemerin and adiponectin while causality regarding all other
endpoints was not significant.
Replication of association signals in the LIFE Leipzig
Heart Study
Replication of top-SNPs was performed in 967 samples of the
LIFE Leipzig Heart Study [15]. All top-SNPs were either directly
measured or imputed with high quality, i.e. no proxies were
required. Replication analysis revealed a clear support of our
results at chr. 7 with similar effect sizes as observed for the Sorbs
and KORA cohort (S7 Table). In contrast, no additional evidence
was generated for the loci at chrs. 3 and 15.
mRNA expression studies
PBMCs. Using mRNA expression data obtained by genome-
wide micro-arrays, we performed an eQTL analysis in PBMCs for
rs7806429 in the Sorbs cohort. The SNP showed the strongest
effect on expressed transcripts for AL359058 (p = 5.1610210,
explained variance = 4.2%) and for LRRC61 (p = 7.861029,
explained variance = 3.7%). The transcripts were not correlated
(r2 = 0.004, p= 0.54) (Table 3). Both transcripts map within the
chromosomal region harbouring variants with the lowest p-values
in the genome wide meta-analysis (about 26 kB from the start site
of AL359058 and about 22 kB from the start site of LRRC61)
suggesting cis regulation. RARRES2 transcripts were not
expressed in PBMCs in our study.
Although we observed the above mentioned strong cis-effects of
our lead SNP, none of the transcripts was associated with
chemerin levels. Consequently, no evidence for a chain of
causation of the form rs7806429Rgene-expressionRserum che-
merin was found (Table 3 and S2 Figure).
Moreover, we extensively searched throughout available online
resources of known eQTLs. Results are summarized in S5 Table.
It revealed that rs7806429 is in linkage disequilibrium (r2.0.5)
with several cis-eQTLs in various tissues including RARRES2 in
Table 1. Correlation of serum chemerin concentrations with anthropometric parameters and markers of glucose metabolism,
serum lipids and renal function in the Sorbs cohort.
Trait p-value ß
%body fat 7.961029 0.008
BMI 2.4610210 0.442
WHR (adj. age, sex) 0.004 0.415
WHR (adj. age, sex, BMI) 0.861 0.028
fasting insulin 3.561024 0.071
HOMA_IR 0.001 0.065
Stumvoll Index 1 0.015 20.119
Stumvoll Index 2 0.002 20.177
AUC glucose 0.033 0.145
AFABP 4.1610211 0.006
progranulin 9.761026 0.181
vaspin 0.344 0.01
adiponectin 0.49 0.023
LDL cholesterol 0.021 0.089
GFR (MDRD) 7.861025 20.255
Associations were assessed in a linear regression model adjusting for age, sex and BMI (except for analysis of BMI itself). HOMA-IR was calculated as published by
Matthews et al. [35]. The Stumvoll Index refers to Stumvoll ISI(0 and 120 min) and Stumvoll ISI(0 and 30 min) [36]. Glomerular filtration rate (GFR) was calculated using the
MDRD formula. ß Beta coefficient of linear regression model.
doi:10.1371/journal.pgen.1004854.t001
Author Summary
Chemerin is an adipokine proposed to link obesity and
chronic inflammation of adipose tissue. In the present
study we show that circulating chemerin is a heritable trait.
In a meta-analysis of genome-wide association studies
(GWAS) of 2,791 individuals from Germany and Finland, we
identified common genetic variants which associate with
serum chemerin levels. The variants map within the
retinoic acid receptor responder 2 (RARRES2)/Leucine Rich
Repeat Containing (LRRC61) at chromosome 7. To better
understand the potential functionality of the identified
variants, we also provide insights into the mRNA expres-
sion of RARRES2 (encoding chemerin) in blood and adipose
tissue. Our results highlight the role and function of
genetic variation in the RARRES2 locus in the regulation of
circulating chemerin concentrations.
Genome Wide Meta-analysis for Chemerin Serum Levels
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brain [16] and lymphoblastoid cell lines [17].
Adipose tissue. We analysed the association of rs7806429
(SNP with the strongest evidence for association with chemerin)
with RARRES2 transcript levels in visceral and subcutaneous
adipose tissue. The SNP rs7806429 was moderately associated
with mRNA expression of RARRES2 in visceral adipose tissue
(Table 4). The association has been driven by SNP effects in
women, whereas no association was found in men (Table 4). Sex-
interaction was not significant. Of note, consistent with correlation
analyses with circulating chemerin, RARRES2 mRNA levels
correlated with anthropometric traits (% body fat), as well as
parameters of glucose homeostasis (fasting plasma glucose, glucose
infusion rate) and lipid metabolism (LDL-cholesterol) (all p,0.05
after adjusting for age, sex and BMI) (S3 Table).
Discussion
Chemerin is an adipokine proposed to link obesity and chronic
inflammation of adipose tissue. Consistent with previous reports
[1,2], serum chemerin concentrations were positively correlated
with BMI and % body fat in our study. Furthermore, chemerin
levels correlated with elevated fasting insulin, HOMA-IR and
AUCglucose. Although serum chemerin levels are heritable, with
estimates of 0.25 in Mexican-Americans [8], studies aimed at
identification of genetic factors explaining the variability in
circulating chemerin levels are lacking. Here, we conducted a
meta-analysis of GWAS for serum chemerin in three independent
cohorts from Europe (Germany and Sweden/Finland). The
heritability of chemerin in the Sorbs cohort was re-estimated to
be 16.2% which is close to the above mentioned estimate. We
found 30 SNPs within the RARRES2-LRRC61 locus on
chromosome 7 which reached genome-wide significance levels in
the meta-analysis. The strongest evidence for association was
observed at rs7806429, which represents a cluster of SNPs in
pairwise LD.
The results of the subgroup analyses in males and females were
consistent with findings in the total cohort. No significant SNP-sex
interaction was observed. Our lead SNP rs7806429 is in LD with
Fig. 1. Regional association plot for the top-hit of association with chemerin levels on chromosome 7.
doi:10.1371/journal.pgen.1004854.g001
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rs10278590 (r2 = 0.64 in the Sorbs cohort) reported to be
associated with visceral fat mass in non-obese subjects [9] but
not with rs17173608 (r2 = 0.049 in the Sorbs cohort) reported to
be associated with the incidence of metabolic syndrome [10].
Mendelian randomization analysis suggests a causal relationship
between chemerin and adiponectin in the Sorbs cohort, which
may appear plausible when considering the potential role of
chemerin in regulation of adipogenesis [5]. Yet, we see these data
with caution since only nominal significance was achieved for the
causality test, i.e. results are not robust against multiple testing
correction.
Noteworthy, despite missing genome-wide significance levels for
association with chemerin, the present GWAS revealed additional
variants on chrs. 3 (lead SNP: rs2594989 in ATG7) and 15 (lead
SNP: rs8027521) definitely deserving further consideration. The
first locus showed consistent effects across all studies. It includes
the ATG7 which seems to be an appealing candidate for metabolic
studies when considering the emerging evidence for the implica-
tion of autophagy in the regulation of adipose tissue and beta cell
functions [18]. Although the precise mechanism by which
autophagy regulates adipogenesis is unknown, it has been shown
that Atg72/2 animals have smaller white adipose tissue depots
and adipocyte-specific knockdown of Atg7 lead to the develop-
ment of brown like adipose tissue [19,20]. One might therefore
hypothesise that any developmental disturbance in autophagy may
affect adipose tissue mass and homeostasis. Thus, alteration in
autophagy caused by genetic variants in autophagy genes (e.g.
ATG7) might result in adverse adipogenesis which consequently
might influence expression of adipokines such as chemerin.
In addition, we tested the association of SNPs reported by
Bozaoglu et al. [8] with chemerin levels in our meta-analysis (S4
Table). Five out of the seven reported SNPs were included in our
meta-analysis. For the other two SNPs we analysed adequate
proxies, namely rs12534101 for rs11971186 (r2 = 0.99) and
rs6701545 for rs4446959 (r2 = 1.0). We observed only nominal
significance of rs1405069 in the Sorbs cohort and of rs347344 in
the PPP cohort, the latter SNP having discordant direction of
effect between cohorts. In the meta-analysis, we observed only
nominal significance for rs1405069 with concordant direction of
effects between cohorts. Hence, we could not convincingly
replicate the hits reported by Bozaoglu et al. These inconsistencies
between the studies could possibly be attributed to different
ethnicities of the studied cohorts (Mexican-Americans vs. Euro-
peans) as well as limited sample size of the previous GWAS by
Bozaoglu et al which only included 523 individuals [8].
To functionally support the present GWAS findings, we sought
to elucidate possible molecular mechanisms underlying the SNP
associations with serum chemerin. An eQTL analysis in PBMCs
revealed a strong association between rs7806429 and mRNA
levels of AL359058 and LRRC61 (also known as FLJ31392,
HSPC295, MGC3036). Both transcripts map within the chro-
mosomal region harbouring variants with lowest p-values in the
chemerin GWAS, thus suggesting cis-regulation of the expression
of corresponding genes. Nevertheless, none of the transcripts
correlated with chemerin levels, i.e. the association between
rs7806429 and serum chemerin does not seem to be mediated by
the mRNA expression of AL359058 or LRRC61 in PBMCs.
Unfortunately, we could not analyse possible SNP associations
with RARRES2 transcripts since these were not expressed in
PBMCs. However, our top-SNP is in linkage disequilibrium with
variants showing eQTL effects of RARRES2 in other tissues such
as brain and lymphoblastoid cell lines [16,17]. In this line,
rs7806429 was associated with mRNA expression of RARRES2 in
visceral adipose tissue of female participants from the Leipzig
cohort. We only detected significant associations in women.
Hence, this result may at least in part suggest that the observed
SNP-chemerin association could be mediated by the role of the
variant in transcription control. It has to be acknowledged though,
that serum chemerin was not available in the Leipzig cohort, i.e.
no direct evidence for correlation between adipose mRNA
expression and serum chemerin could be tested. Nevertheless,
consistent correlations of metabolic parameters with both,
RARRES2 mRNA expression in the Leipzig cohort as well as
serum chemerin in the Sorbs cohort suggests a relationship of
RARRES2 expression in fat tissue and circulating chemerin levels
which could explain the observed SNP-chemerin associations.
Further support comes from Min et al. who employed a whole-
genome expression and genotype profiling on abdominal adipose
tissue and found that rs10282458, an eSNP affecting expression of
RARRES2, was associated with BMI [11]. It is noteworthy that
rs7806429, the lead SNP from our study, is in high LD (r2.0.7)
with rs10282458, which however, was not included in our meta-
analysis due to quality issues. On the other side, we further
checked for potential associations in publically available GWAS
datasets from GIANT consortium (http://www.broadinstitute.
org/collaboration/giant/index.php/GIANT_consortium) and found
rs7806429 being nominally associated with BMI (p= 0.01; N=
123,835). In contrast, no associations were observed for glucose and
insulin related traits in the GWAS dataset fromMAGIC consortium
(http://www.magicinvestigators.org).
Moreover, functional consequences of the associated SNPs were
predicted using the RegulomeDB [21]. Including all 26 SNPs in
strong LD with rs7806429 (based on r2.0.8 in HapMap CEU
population), we identified 17 variants reaching a score of 1,
suggesting that these polymorphisms might explain an eQTL or
affect corresponding transcription factor binding sites. For
example, as shown for rs17173617, the reported eQTL associates
with the expression of LRRC61, RARRES2 and C7orf29 in
lymphoblastoid cell types [17,22]. Regarding to transcription
factor binding sites, it is noteworthy that rs2108854 maps within
the FOXP1 [23], rs3735171 within the AP-4 [23,24] or Brn-2 and
rs11769348 within the NFE2L2 binding motif [24]. These data
strongly suggest causative variants within the chemerin-associated
locus and warrant further in-depth functional analyses to elucidate
molecular mechanisms underlying the observed associations.
Finally, we would like to note that it may not appear surprising
that variants associated with circulating chemerin map within a
locus including the RARRES2 which itself encodes chemerin.
However, history of GWAS showed that biologically plausible
genes do not necessarily point towards easily identifiable risk
variants. Indeed, our locus was not discovered by the previous
GWAS for chemerin [8].
In conclusion, the present meta-analysis of GWAS for serum
chemerin levels is the first study to demonstrate robust SNP-
associations reaching genome-wide significance and highlights the
role of genetic variation in the RARRES2 in the regulation of
circulating chemerin concentrations possibly caused by altered
gene expression in fat tissue.
Materials and Methods
Subjects
Sorbs cohort. The cohort was recruited from the self-
contained Sorbs population in Germany [25–28]. Extensive
phenotyping included standardized questionnaires to assess past
medical history and family history, collection of anthropometric
data (weight, height, waist-to-hip ratio (WHR)), and an oral
glucose tolerance test (OGTT). Glucose was assessed by the
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Hexokinase method (Automated Analyser Modular, Roche
Diagnostics, Mannheim, Germany) and serum insulin was
measured using the AutoDELFIA Insulin assay (PerkinElmer Life
and Analytical Sciences, Turku, Finland). Chemerin serum
concentrations in the three cohorts were determined using a
commercially available ELISA kit (Human Chemerin ELISA,
Biovendor, Heidelberg, Germany) according to the manufactur-
er’s instructions. Blood samples were taken in the morning after an
overnight fast and stored at 280uC until analyses. The sensitivity
of the chemerin ELISA assay was 0.1 ng/ml. The degree of
precision of the ELISA system in terms of coefficient of variance
(%) of intra-assay was 6% (within-run, n = 8), that of inter-assays
was 7.6% (run-to-run, n= 6).
In the current study, the cohort included 824 Sorbs without type
2 diabetes, with complete genotype, covariate and phenotype
information (S1 Table). The study was approved by the ethics
committee of the University of Leipzig and all subjects gave
written informed consent before taking part in the study.
KORA. The Cooperative Health Research in the Region of
Augsburg (KORA) study is a series of independent population-
based epidemiological surveys and follow-up studies of participants
living in the region of Augsburg, Southern Germany. All
participants are residents of German nationality identified through
registration. Informed consent has been given by all participants
[29] and the study has been approved by the local ethics
committee. The present study includes data of the KORA follow-
up study F4 (2006–2008). For the genome-wide association study,
we genotyped 1,814 randomly selected participants of KORA F4.
1630 subjects without type 2 diabetes were included in the present
study. Chemerin serum concentrations were determined using a
commercially available ELISA (Human Chemerin ELISA,
Biovendor, Heidelberg, Germany) as described above. Detailed
phenotypic information is provided in S1 Table.
Prevalence, Prediction and Prevention of diabetes (PPP)-
Botnia Study. The Prevalence, Prediction and Prevention of
diabetes (PPP)–Botnia Study is a population-based study from the
Botnia region of western Finland [30]. In the present study, 337
subjects with normal glucose tolerance from PPP that also
participated in the Diabetes Genetics Initiative (DGI) were
included [31]. Chemerin serum concentrations were determined
using a commercially available ELISA kit (Human Chemerin
ELISA, Biovendor, Heidelberg, Germany) as described above.
Participants gave their written informed consent and the study
protocol was approved by the Ethics Committee of Helsinki
University Hospital, Finland.
LIFE Leipzig Heart Study. This is an observational study
recruiting individuals with suspected coronary artery disease due
to clinical symptoms (non-invasive testing), with stable left main
coronary artery disease or myocardial infarction. Details of the
study can be found elsewhere [15]. The study meets the ethical
standards of the Declaration of Helsinki. It has been approved by
the Ethics Committee of the Medical Faculty of the University
Leipzig, Germany (Reg. No 276-2005) and is registered at
ClinicalTrials.gov (NCT00497887).
In the present study, 967 nondiabetic subjects were included.
Chemerin was measured by a commercially available ELISA
(Mediagnost, Reutlingen,Germany) adapted on the DSX auto-
matic ELISA test system. The analytical sensitivity was 0.005 ng/
mL. Intra and inter assay coefficient of variation were found to be
4.9% at a concentration of 61.8 ng/mL and 6.3% at a
concentration of 144 ng/mL (n= 15) chemerin.
Written informed consent including agreement with genetic
analyses was obtained from all participants enrolled in the
study.
Leipzig adipose tissue samples
Paired samples of visceral (vis) and subcutaneous (sc) adipose
tissue were obtained from 636 Caucasian men (N= 203) and
women (N= 433), undergoing open abdominal surgery. The
subjects had a mean age of 50614 years and a mean BMI of
43.9612.9 kg/m2 (women: 49613 years and 44.5612.3 kg/m2;
men: 53615 years and 42.8614.2 kg/m2). All subjects main-
tained a stable weight (within 2% of the body weight) for at least 3
months before surgery. Patients with severe conditions including
generalized inflammation or end-stage malignant diseases were
excluded from the study. Samples of vis and sc adipose tissue were
immediately frozen in liquid nitrogen after explantation. An
OGTT was performed after an overnight fast with a 75 g
standardized glucose solution (Glucodex Solution 75 g; Merieux,
Montreal, Canada). In addition to the above mentioned clinical
parameters, abdominal vis and sc fat area were calculated using
computed tomography scans at the level of L4-L5, and percentage
body fat was measured by dual-energy X-ray absorptiometry
(DEXA).
The ethics committee at the Medical Faculty of the University
of Leipzig specifically approved this study, and all subjects gave
written informed consent before taking part in the study.
Genotyping, quality control and genotype imputations
Sorbs cohort. Subjects were genotyped either by 500 K
Affymetrix GeneChip or by Affymetrix Genome-Wide Human
SNP Array 6.0. The BRLMM algorithm (Affymetrix, Inc) was
applied for the 500 K array and the Birdseed algorithm was
applied for the Genome-Wide Human SNP Array 6.0. Quality
control of samples was performed as described in Gross et al. [26],
resulting in N=977 individuals with genotypes of good quality
(N= 483 genotyped with the 500 K assay, N=494 genotyped with
the 6.0 assay). Genotype imputation was performed separately for
individuals genotyped with the two different assays. No prior SNP
filtering was performed. Imputation was performed with IMPUTE
v2.1.2 (http://mathgen.stats.ox.ac.uk/impute/impute_v2.html) using
HapMap2 CEU, Release 24, dbSNP-build 126, NCBI 36 as
the reference panel. To detect ethnical outliers, we applied a
‘drop one in’ procedure to avoid bias by the relatedness
structure within the Sorbs cohort [28]. We performed one PCA
for each Sorbian individual together with 50 most unrelated
HapMap CEU individuals based on genotype data as explained
in Gross et al [26]. Resulting eigenvectors of CEU individuals
were averaged over all iterations. Individuals were considered as
ethnical outliers if the distance from the mean of the respective
eigenvector of at least one of the first 10 eigenvectors exceeds 6
sd. After application of filtering, three individuals were discarded
from association analysis (final N= 824). Details are provided in
S1 Table.
KORA. Subjects were genotyped at the Helmholtz Genome
Analysis Center using Affymetrix 6.0 arrays. The Birdseed 2
calling algorithm was applied. Imputations were performed with
IMPUTE v0.4.2 on HapMap Phase 2 CEU as a reference panel
(details see S1 Table).
PPP. Subjects were genotyped at the Broad Institute using the
Affymetrix GeneChip Human Mapping 500 K Array Set. The
BRLMM algorithm was applied. Imputations were performed
with MACH on HapMap Phase 2 CEU as the reference panel
(details see S1 Table).
LIFE Leipzig Heart Study. Genotyping was performed
using the Affymetrix Axiom Technology with custom option
(Axiom-CADLIFE). Genotype calling was performed with Affy-
metrix Power Tools version 1.12. Sample quality control
comprised call rate (.97%), hetero- or homozygosity excess
Genome Wide Meta-analysis for Chemerin Serum Levels
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(outliers of mean squared differences of observed and expected
genotypes), sex-mismatch, cryptic relatedness, and outliers of
principal components analysis (6SD criterion of Eigenstrat
software) [32]. Prior to imputation, low quality SNPs defined by
low call-rate (,90% plate-wise call rate corresponding to ,94.2%
overall call-rate), deviation from Hardy-Weinberg equilibrium (p,
1026) or plate-association (p,1027) were filtered. Individuals were
imputed at the 1000Genomes reference phase 1, release 3 (http://
mathgen.stats.ox.ac.uk/impute/data_download_1000G_phase1_
integrated.html) using SHAPEIT v2 and IMPUTE 2.3.0. For
post-imputation quality control we filtered SNP with minor allele
frequency,1% or info-score,0.3.
Genotyping of rs7806429 in the Leipzig cohort
De novo genotyping of the SNP rs7806429 was done using the
TaqMan SNP Genotyping assays according to the manufacturer’s
protocol (Applied Biosystems, Inc., Foster City, CA). To validate
the reproducibility of genotyping, a random subset (about 5%) of
the sample was re-genotyped; all genotypes matched initial
designated genotypes. No deviations from HWE were observed
(p.0.1).
Association studies and meta-analysis
Association between circulating chemerin levels and
anthropometric traits. Before analyses, all non-normally
distributed parameters were logarithmically transformed (% body
fat, BMI, WHR, fasting insulin, HOMA-IR, Stumvoll index, AUC
glucose, AFABP, progranulin, vaspin, adiponectin, chemerin,
LDL cholesterol, glomerular filtration rate). Linear regression
models adjusted for age, sex, and BMI (only age and sex for BMI
analysis) were calculated using SPSS software version 20.0 (SPSS,
Chicago, IL).
Genome wide association analysis. Chemerin serum levels
were log-transformed prior to analysis. Genetic associations were
assessed using linear regression analyses of allele doses adjusting
for age, sex and BMI. In the Sorbs cohort, we additionally
adjusted for relatedness using mixed effect models (function
‘‘polygenic’’ of the ‘‘GenABEL’’ package of R) [12,13]. We also
performed sub-group analyses in males and females. Meta-analysis
was performed for SNPs fulfilling the quality control criteria in all
three cohorts (see section ‘‘Genotyping, quality control and
genotype imputations’’). SNPs with allele frequencies differing by
more than 20% between cohorts were discarded. According to this
criterion, a total of 2,023,499 SNPs were analysed. Prior to meta-
analysis, effect sizes of single studies were corrected for inflation
(Sorbs cohort: l=1.014, KORA: l=0.99, PPP: l=0.99).
Standardized effects of single studies were combined using fixed
and random effects models (function ‘‘metagen’’ of the ‘‘meta’’
package of R). Heterogeneity between studies was assessed by Q-
statistics.
Functional consequences of the associated SNPs using
RegulomeDB
Potential functional consequences of the associated SNPs were
analysed using the RegulomeDB [21]. Briefly, RegulomeDB is a
database that annotates SNPs with known and predicted
regulatory elements in the human genome, such as DNAase
hypersensitivity, binding sites of transcription factors, and
promoter regions.
Mendelian randomisation
Finally, a Mendelian randomization analysis was performed
using our top-associated SNP as an instrumental variable [33].
This analysis aimed at establishing causal links between chemerin
and other parameters of obesity and the metabolic syndrome as
presented in Table 1.
Replication analysis
Replication of top-SNPs was performed in samples of the LIFE
Leipzig Heart Study. Top-SNPs to be replicated were retrieved
from these data by searching for well-imputed proxies using SNAP
(https://www.broadinstitute.org/mpg/snap/ldsearch.php).
For a total of 967 non-diabetic individuals, both, chemerin
measurements with adequate covariate information and SNP data
were available. For replication analysis, we analysed additive
models of chemerin-SNP associations adjusting for age, sex and
BMI as in the cohorts of the meta-analysis. Taking into account
the characteristics of the LIFE LeipzigHeart study population, we
also adjusted for fasting status and disease status (coronary artery
disease case/control status).
mRNA expression studies
RNA expression profiling in PBMCs in the Sorbs
cohort. PBMCs were extracted from blood samples collected in
VACUTAINER CPT (Cell Preparation Tubes) containing sodium
heparin as the anti-coagulant according to the manufacturer’s
protocol (BD, Franklin Lakes, NJ). RNA from PBMCs was
extracted using the TRIzol protocol (Thermo Fisher Scientific).
DNase I digestion of the RNA samples was performed with
subsequent RNA clean-up using the RNeasyMinElute Cleanup Kit
(Qiagen, Hilden, Germany). RNA integrity and concentration were
examined using an Agilent 2100 Bioanalyzer (Agilent Technologies,
Palo Alto, CA, USA) using the RNA 6.000 LabChip Kit (Agilent
Technologies) according to the manufacturers’ instructions. Illu-
mina GeneChip analyses were conducted at the microarray core
facility of the Interdisciplinary Centre for Clinical Research (ICCR)
in Leipzig (Dr. Krohn, Faculty of Medicine, University of Leipzig).
250 ng of total RNA was reverse transcribed cDNA (Target Amp
labelling kit (Illumina, SanDiego, CA, USA and Superscript III, Life
Technologies, Gaithersburg, MD, USA), which was further
synthesized to cRNA by in vitro transcription (Superscript III, Life
Technologies, Gaithersburg, MD, USA and Target Amp labelling
kit, Illumina, SanDiego, CA, USA). Subsequently, unincorporated
nucleotides were removed using the RNeasy kit (QIAGEN, Hilden,
Germany) and the cRNA was hybridized to the Illumina Human
HT-12 v4 Bead Chip.Washing and staining of the probe array were
performed according to the manufacturers’ instructions. The arrays
were scanned using an Illumina High Scan SQ.
For data analysis, probe set fluorescence intensities were
extracted for available transcripts and were scaled to normalize
data for inter-array comparison using High Control software
(Illumina, San Diego, CA, USA).
Pre-processing of RNA microarray data
Pre-processing of RNA microarray data relied on the intensities
of 47,323 transcripts derived from Illumina BeadStudio without
background correction and normalization measured in 1,029
individuals of the Sorbs cohort. Steps for pre-processing comprised
1. filtering of individuals with atypical low number of expressed
genes (median - 3 interquartile ranges (IQR) of the cohort’s
values), 2. quantile normalization and log2- transformation, 3.
filtering individuals with atypical gene-expression profiles (Euclid-
ian distance to average expression larger than median +3 IQR), 4.
filtering individuals with atypical values of internal quality
parameters (quantified as Mahalanobis distance of quality control
probes included on the HT-12 v4 chip by Illumina, individuals
having a larger value than median +3 IQR of this measure were
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excluded), 5. correcting for batch effects on the basis of
hybridisation chip numbers using Empirical Bayes estimates
[34], 6. linear adjustment for age, sex, and lymphocyte and
monocyte cell counts. A total of 924 individuals fulfilled all quality
criteria. For 898 of these, SNP array data were also available for
eQTL analyses.
Gene-expression analyses of PBMCs in the Sorbs cohort
To provide functional evidence for the SNPs with the strongest
evidence for association in the meta-analysis, we performed eQTL
analyses in PBMCs including all SNPs reaching genome-wide
significant association with chemerin serum levels. Moreover, we
examined potential correlations between the corresponding regu-
lated transcripts and chemerin levels. Finally, we tested for causal
relationships between top-SNPs, gene-expression and chemerin
levels by comparing effect sizes (beta-coefficients) of SNPs between
the two linear models: ‘‘chemerin depending on SNP’’ and
‘‘chemerin depending on regulated gene-expression and SNP’’.
Human adipose tissue expression of RARRES2 in the
Leipzig cohort
To measure human adipose tissue expression of RARRES2 in
the Leipzig cohort, total RNA was isolated from paired
subcutaneous and visceral adipose tissue samples using TRIzol
(Life Technologies, Grand Island, NY), and 1 mg RNA was
reversely transcribed using standard reagents (Life Technologies).
RARRES2 mRNA expression was measured by quantitative real-
time RT-PCR using TaqMan methodology, and fluorescence was
detected on an ABI PRISM 7500 sequence detector according to
the manufacturer’s instructions (Applied Biosystems, Darmstadt,
Germany). Human RARRES2 mRNA expression was calculated
relative to the mRNA expression of HPRT and 18S rRNA,
determined by a premixed assay on demand (PE Biosystems,
Darmstadt, Germany). The specificity of the PCR was further
verified by agarose gel electrophoresis.
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